Sigyn Therapeutics, Inc. filed its 10-K on Mar 21, 2022 for the period ending Dec 31, 2021. In this report its auditor, Benjamin & Ko, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | +5.00% | +5.00% | +10.99% |
Feb. 20 | Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer | CI |
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- SIGY Stock
- News SIGN THERPAR
- Sigyn Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt